Non-Small Cell Lung Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We found that the high expression of CBLL1 was associated with the tumor size in NSCLC tissues.
|
31124298 |
2019 |
Non-Small Cell Lung Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, CBLL1 overexpression could abolish the effects of miR-212-3p overexpression on NSCLC cell proliferation, migration, invasion and EMT in vitro.
|
31646569 |
2019 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
We found that the high expression of CBLL1 was associated with the tumor size in NSCLC tissues.
|
31124298 |
2019 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
There were no differences in CDH1, SNAI1 and HAKAI mRNA expression between tumor and corresponding peritumoral samples and no differential tumoral gene expression according to nodal involvement.
|
19893985 |
2009 |
Malignant neoplasm of breast
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
While, the overexpression of CBLL1 inhibited the estrogenic dependent cell proliferation and migration in ER alpha dependent breast cancer cell MCF-7.
|
31124298 |
2019 |
Malignant Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In this study, we found that CBLL1 was frequently upregulated in non-small lung cancer (NSCLC) tissues compared to the adjacent nontumor tissues.
|
31124298 |
2019 |
Malignant tumor of colon
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CBLL1 is over-expressed in colon cancer and associated with cancer cell proliferation.
|
31124298 |
2019 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Studies have shown that E3 ubiquitin ligase CBLL1 plays multiple roles in development and tumorigenesis.
|
31124298 |
2019 |
Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
While, the overexpression of CBLL1 inhibited the estrogenic dependent cell proliferation and migration in ER alpha dependent breast cancer cell MCF-7.
|
31124298 |
2019 |
Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CBLL1 is over-expressed in colon cancer and associated with cancer cell proliferation.
|
31124298 |
2019 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
It has been recently reported that CBLL1 promotes cell proliferation and invasion in A549 and H460 cells.
|
31124298 |
2019 |
Primary malignant neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In this study, we found that CBLL1 was frequently upregulated in non-small lung cancer (NSCLC) tissues compared to the adjacent nontumor tissues.
|
31124298 |
2019 |
Progression of non-small cell lung cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results provide important insights for using CBLL1 as an oncogenic marker gene in the development and progression of non-small cell lung cancer.
|
31124298 |
2019 |
Neoplasm Metastasis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
We compared CDH1, SNAI1 and HAKAI mRNA expression in IDC and paired adjacent normal breast tissue and evaluated its relation with node metastasis and circulating tumor cells.
|
19893985 |
2009 |
West Nile viral infection
|
0.010 |
Biomarker
|
disease |
BEFREE |
We further demonstrate a requirement for the ubiquitin ligase CBLL1 in WNV internalization, a post-entry role for the endoplasmic-reticulum-associated degradation pathway in viral infection, and the monocarboxylic acid transporter MCT4 as a viral replication resistance factor.
|
18690214 |
2008 |